German pharma giant Bayer has announced this month that it will be working with 11 additional startups to accelerate the development of digital products improving patients’ health through its G4A Digital Health Partnerships programme.
The startups, which look at oncology, cardiovascular diseases and others, were selected from over 750 applications spanning 65 countries based on the development...
